EMEA-001230-PIP01-11-M05

Key facts

Invented name
Latuda
Active substance
Lurasidone hydrochloride
Therapeutic area
Psychiatry
Decision number
P/0359/2019
PIP number
EMEA-001230-PIP01-11-M05
Pharmaceutical form(s)
Film-coated tablet
Condition(s) / indication(s)
Treatment of schizophrenia
Route(s) of administration
Oral use
Contact for public enquiries
AZIENDE CHIMICHE RIUNITE ANGELINI FRANCESCO - A.C.R.A.F. S.p.A.

Tel.  +39 0691045515
E-mail: c.costa@angelini.it

Decision type
PM: decision on the application for modification of an agreed PIP

Decision

How useful was this page?

Add your rating
Average
2 ratings